Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
eHealth Inc has a consensus price target of $6.14 based on the ratings of 7 analysts. The high is $11 issued by RBC Capital on November 25, 2024. The low is $2 issued by Craig-Hallum on February 26, 2026. The 3 most-recent analyst ratings were released by RBC Capital, Craig-Hallum, and RBC Capital on March 11, 2026, February 26, 2026, and November 25, 2025, respectively. With an average price target of $4.67 between RBC Capital, Craig-Hallum, and RBC Capital, there's an implied 253.54% upside for eHealth Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for eHealth (NASDAQ:EHTH) was reported by RBC Capital on March 11, 2026. The analyst firm set a price target for $3.00 expecting EHTH to rise to within 12 months (a possible 127.27% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for eHealth (NASDAQ:EHTH) was provided by RBC Capital, and eHealth maintained their sector perform rating.
The last upgrade for eHealth Inc happened on November 6, 2024 when Craig-Hallum raised their price target to $7. Craig-Hallum previously had a hold for eHealth Inc.
The last downgrade for eHealth Inc happened on February 26, 2026 when Craig-Hallum changed their price target from N/A to $2 for eHealth Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of eHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for eHealth was filed on March 11, 2026 so you should expect the next rating to be made available sometime around March 11, 2027.
While ratings are subjective and will change, the latest eHealth (EHTH) rating was a maintained with a price target of $9.00 to $3.00. The current price eHealth (EHTH) is trading at is $1.32, which is out of the analyst’s predicted range.